Immune Checkpoint Inhibitors in the Treatment of Patients with Neuroendocrine Neoplasia. [electronic resource]
Producer: 20190819Description: 306-312 p. digitalISSN:- 2296-5262
- Antineoplastic Agents, Immunological -- pharmacology
- B7-H1 Antigen -- antagonists & inhibitors
- Clinical Trials, Phase II as Topic
- Disease Progression
- Humans
- Microsatellite Instability
- Neoplasm Grading
- Neuroendocrine Tumors -- drug therapy
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.